Despite increasing numbers of organ transplants completed each year, there continues to be an organ shortage in liver transplantation. This has led to the utilization of previously discarded or "marginal" allografts, such as those from donors with hepatitis C virus (HCV) or hepatitis B virus (HBV). The advent of direct acting antivirals and nucleos(t)ide analogs has allowed these allografts to be safely transplanted regardless of the recipients' hepatitis status with comparable graft and patient survival. Recent advances have even allowed usage of actively viremic donors with similar graft and patient outcomes. This article presents an overview of the use of HCV positive and HBV positive allografts. Copyright © 2023 Elsevier Inc. All rights reserved.
Sara-Catherine Whitney Zingg, Kristina Lemon. Donor Viral Hepatitis and Liver Transplantation. The Surgical clinics of North America. 2024 Feb;104(1):67-77
PMID: 37953041
View Full Text